Skip to main
SGTX
SGTX logo

Sigilon Therapeutics (SGTX)

$0.00

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Buy Sigilon Therapeutics (SGTX) Stock

About Sigilon Therapeutics (SGTX)

Sigilon Therapeutics, Inc. is a biopharmaceutical company, which engages in the research and development of therapeutic treatments for a wide range of chronic diseases. Its program includes Rare Blood Disorders, Lysosomal Storage Diseases, and Endocrine and Other Chronic Diseases. The company was founded by Daniel G. Anderson, Robert S. Langer Jr., Jose Oberholzer, Arturo Vegas, and Omid Veiseh on...read more
Market cap$56.49M
Today's volume
Revenue (TTM)
Avg. daily volume118.46K
EBITDA (TTM)
Open
Price / earnings ratio-1.86x
Today's range
Debt / equity
52 week range$3.77 - $28
5 year debt / equity-31.72x
Beta (LTM)0.56x
Interest coverage
Dividend & yield$0.00 (0.00%)
Current ratio
Ex-dividend date
Next earningsDec 6, 2024
Dividend payable date

Frequently Asked Questions (FAQ)

As of Jun 22, 2025, the market cap for SGTX stock is $56.49M

The current P/E ratio for SGTX stock is -1.86

The 52-week high for SGTX stock is $28. The current SGTX stock price $undefined is 100.00% below its 52-week high

The 52-week low for SGTX stock is $3.77. The current SGTX stock price $undefined has increased 100.00% from its 52-week low

No, the SGTX stock does not pay dividends to its shareholders

How to buy SGTX stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in SGTX stock

    Navigate to the Explore page. Then, type SGTX into the search bar. When you see SGTX stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased SGTX stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

Sigilon Therapeutics Stock Earnings

The value each SGTX share was expected to gain vs. the value that each SGTX share actually gained.

Sigilon Therapeutics (SGTX) reported Q2 2023 earnings per share (EPS) of -$3, beating estimates of -$4.71 by 36.31%. In the same quarter last year, Sigilon Therapeutics's earnings per share (EPS) was -$5.72. Sigilon Therapeutics is expected to release next earnings on 12/06/2024, with an earnings per share (EPS) estimate of $0.

Buy Sigilon Therapeutics (SGTX) Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.